{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:26:09Z","timestamp":1757701569148,"version":"3.28.2"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,26]]},"DOI":"10.7759\/cureus.74511","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:14:17Z","timestamp":1732641257000},"source":"Crossref","is-referenced-by-count":1,"title":["Pemphigus vulgaris Treated With Rituximab: A Case Report"],"prefix":"10.7759","author":[{"given":"Guilherme N","family":"Faria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Sardinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)","volume":"29","author":"Joly P","year":"2011","unstructured":"Joly P, Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol. 2011, 29:432-6. 10.1016\/j.clindermatol.2011.01.013","journal-title":"Clin Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017","volume":"177","author":"Harman KE","year":"2017","unstructured":"Harman KE, Brown D, Exton LS, et al.. British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017. Br J Dermatol. 2017, 177:1170-201. 10.1111\/bjd.15930","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0353-6","article-title":"Pemphigus vulgaris: an evidence-based treatment update","volume":"75","author":"Zhao CY","year":"2015","unstructured":"Zhao CY, Murrell DF. Pemphigus vulgaris: an evidence-based treatment update. Drugs. 2015, 75:271-84. 10.1007\/s40265-015-0353-6","journal-title":"Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell DF","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, et al.. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008, 58:1043-6. 10.1016\/j.jaad.2008.01.012","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori L","year":"2022","unstructured":"Borradori L, Van Beek N, Feliciani C, et al.. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2022, 36:1689-704. 10.1111\/jdv.18220","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2116","article-title":"Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens","volume":"95","author":"Wang HH","year":"2015","unstructured":"Wang HH, Liu CW, Li YC, Huang YC. Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens. Acta Derm Venereol. 2015, 95:928-32. 10.2340\/00015555-2116","journal-title":"Acta Derm Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly P","year":"2017","unstructured":"Joly P, Maho-Vaillant M, Prost-Squarcioni C, et al.. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. Lancet. 2017, 389:2031-40. 10.1016\/s0140-6736(17)30070-3","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306845-pemphigus-vulgaris-treated-with-rituximab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:14:18Z","timestamp":1732641258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306845-pemphigus-vulgaris-treated-with-rituximab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.74511","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,26]]}}}